CASI Pharmaceuticals annual operating margin
2020
2021
2022
2023
2024
2025
CASI Pharmaceuticals Operating Margin Growth & History (CASIF)
CASI Pharmaceuticals's operating margin was −217.30% for fiscal 2025.
View full CASI Pharmaceuticals company overviewCASI Pharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −217.30% | −78.46 pp |
| 2024 | 2024-12-31 | −138.84% | −64.81 pp |
| 2023 | 2023-12-31 | −74.03% | +15.42 pp |
| 2022 | 2022-12-31 | −89.45% | +48.85 pp |
| 2021 | 2021-12-31 | −138.29% | +213.56 pp |
| 2020 | 2020-12-31 | −351.85% | — |
CASI Pharmaceuticals quarterly operating margin
No reported data
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
CASI Pharmaceuticals operating margin trends
Over the last five reported fiscal years, CASI Pharmaceuticals's operating margin increased from −351.85% to −217.30%, a change of +134.55 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CASI Pharmaceuticals filings at SEC.gov ↗